FDA Launches Rare Disease Framework Initiative for Fit-For-Purpose Rules

The FDA's Rare Disease Framework Initiative seeks fit-for-purpose regulatory standards for drugs and biologics intended for rare diseases, signalling coming changes to review pathways with no binding requirements yet set.